Laman UtamaCMXHF • OTCMKTS
add
CSL Ltd
Tutup sebelumnya
$170.75
Julat tahun
$162.94 - $210.49
Permodalan pasaran
134.29B AUD
Bilangan Purata
439.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
ASX
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Jun 2024info | Perubahan T/T |
---|---|---|
Hasil | 3.37B | 10.14% |
Perbelanjaan pengendalian | 1.05B | 12.78% |
Pendapatan bersih | 370.50J | 29.77% |
Margin untung bersih | 10.98 | 17.81% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 788.00J | 3.01% |
Kadar cukai berkesan | 20.28% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Jun 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 1.66B | 7.04% |
Jumlah aset | 38.02B | 4.93% |
Jumlah liabiliti | 18.62B | 1.16% |
Jumlah ekuiti | 19.40B | — |
Syer tertunggak | 483.25J | — |
Harga kepada buku | 4.75 | — |
Pulangan pada aset | 4.22% | — |
Pulangan pada modal | 5.08% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Jun 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | 370.50J | 29.77% |
Tunai daripada operasi | 847.50J | 4.57% |
Tunai daripada pelaburan | -278.50J | 22.53% |
Tunai daripada pembiayaan | -235.00J | 43.37% |
Perubahan bersih dalam tunai | 316.00J | 1,139.22% |
Aliran tunai bebas | 348.19J | 93.30% |
Perihal
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Diasaskan
1916
Ibu pejabat
Tapak web
Pekerja
32,698